Contact Lens & Anterior Eye最新文献

筛选
英文 中文
Orthokeratology with the trial lens fitting and software fitting 角膜塑形镜试戴和软件验配
IF 4.1 3区 医学
Contact Lens & Anterior Eye Pub Date : 2024-08-01 DOI: 10.1016/j.clae.2024.102197
{"title":"Orthokeratology with the trial lens fitting and software fitting","authors":"","doi":"10.1016/j.clae.2024.102197","DOIUrl":"10.1016/j.clae.2024.102197","url":null,"abstract":"","PeriodicalId":49087,"journal":{"name":"Contact Lens & Anterior Eye","volume":null,"pages":null},"PeriodicalIF":4.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141951418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Add-on effect of using 0.05% atropine in fast progressors of orthokeratology: A preliminary retrospective study. 使用 0.05% 阿托品对角膜矫形术快速进展者的附加效果:初步回顾性研究
IF 4.1 3区 医学
Contact Lens & Anterior Eye Pub Date : 2024-07-27 DOI: 10.1016/j.clae.2024.102282
Longbo Wen, Hong Liu, Qinglin Xu, Wei Pan, Zhenghua Lin, Zhigang Xiao, Zhikuan Yang, Weizhong Lan, Zhao Chen
{"title":"Add-on effect of using 0.05% atropine in fast progressors of orthokeratology: A preliminary retrospective study.","authors":"Longbo Wen, Hong Liu, Qinglin Xu, Wei Pan, Zhenghua Lin, Zhigang Xiao, Zhikuan Yang, Weizhong Lan, Zhao Chen","doi":"10.1016/j.clae.2024.102282","DOIUrl":"https://doi.org/10.1016/j.clae.2024.102282","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the potential benefit of combining orthokeratology (OK) lenses with 0.05% atropine ophthalmic solution on the efficacy of myopia control in the fast progressors of OK.</p><p><strong>Methods: </strong>Average axial length (AL) elongation of both eyes in 70 participants using OK lenses alone or OK lenses combined with 0.05 % atropine ophthalmic solution was retrospectively reviewed. During the observation period (phase 1), all participants exhibited an AL elongation that exceeded 0.15 mm over a 6-month period or 0.3 mm over a 12-month period. Subsequently, the participants were divided into two groups: one group received nightly 0.05 % atropine ophthalmic solution in addition to OK lenses for another 1 year (OKA), while the other group continued using OK lenses alone (phase 2). The changes in AL elongation over time and the differences in AL elongation between the two groups were then compared.</p><p><strong>Results: </strong>The baseline and phase 1 demographics and characteristics of the participants was similar between the two groups (all p > 0.05). when considering a one-year timeframe, the OKA group displayed a significantly less AL elongation compared to the OK group (0.14 ± 0.13 mm vs 0.27 ± 0.12 mm, p < 0.001). Within the OKA group, the AL elongation in the second half of the year was significantly faster than in the first half (0.12 ± 0.11 mm vs 0.02 ± 0.14 mm, p = 0.01). Conversely, there was no significant difference in AL elongation between the OK group in the first and second half of the year (0.12 ± 0.07 mm vs 0.15 ± 0.08 mm, p = 0.71). The combination of 0.05 % atropine ophthalmic solution had a significant effect on 1-year AL elongation (p < 0.001).</p><p><strong>Conclusions: </strong>This study provided preliminary evidence that the combination of OK lenses and 0.05% atropine ophthalmic solution can significantly enhance the effectiveness of myopia control.</p>","PeriodicalId":49087,"journal":{"name":"Contact Lens & Anterior Eye","volume":null,"pages":null},"PeriodicalIF":4.1,"publicationDate":"2024-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141789564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term effect of orthokeratology on controlling myopia progression in children with allergic conjunctivitis. 正视镜对控制过敏性结膜炎患儿近视发展的长期效果。
IF 4.1 3区 医学
Contact Lens & Anterior Eye Pub Date : 2024-07-23 DOI: 10.1016/j.clae.2024.102280
Xiaoguang Niu, Hongda Zhang, Mengxue Zhang, Shujuan Wu, Guimei Xia, Man Xu
{"title":"Long-term effect of orthokeratology on controlling myopia progression in children with allergic conjunctivitis.","authors":"Xiaoguang Niu, Hongda Zhang, Mengxue Zhang, Shujuan Wu, Guimei Xia, Man Xu","doi":"10.1016/j.clae.2024.102280","DOIUrl":"https://doi.org/10.1016/j.clae.2024.102280","url":null,"abstract":"<p><strong>Background: </strong>To observe whether the effect of orthokeratology (OK) lenses on myopia control in children with allergic conjunctivitis (AC) after three years of wear differs from that in children without allergic conjunctivitis (nAC) and to identify the potential influencing factors.</p><p><strong>Methods: </strong>This was a retrospective case-control study. Patients aged 8-15 years who were fitted with OK lenses in 2019 were collected. A three-year follow-up was also conducted, documenting all corneal adverse events (AEs) and the increase in axial length (AL) of the eye after three years of wearing OK lenses. Patients were divided into groups with and without AC based on their medical history and physical signs at the initial fitting. Baseline data and AL elongation after three years were compared between the two groups.</p><p><strong>Results: </strong>A total of 309 patients were included in this study, with 47 in the AC group and 262 in the nAC group. There were no statistically significant differences between the two groups in terms of age, sex, spherical equivalent (SE), AL of the eye and environment. After three years of OK lens wear, the AL elongation in the AC group was 0.96 ± 0.45 mm, whereas it was 0.69 ± 0.45 mm in the nAC group (P < 0.001). The extent of AL elongation in AC patients was significantly greater than that in nAC patients. During the three-year follow-up period, the duration of OK lenses discontinuation due to corneal AEs in the AC group was greater than that in the nAC group (P < 0.05).</p><p><strong>Conclusions: </strong>This study found that allergic conjunctivitis can affect the efficacy of OK lenses in controlling myopia after three years of treatment.</p>","PeriodicalId":49087,"journal":{"name":"Contact Lens & Anterior Eye","volume":null,"pages":null},"PeriodicalIF":4.1,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141762004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The efficacy of vitamin D supplementation in dry eye disease: A systematic review and meta-analysis 维生素 D 补充剂对干眼症的疗效:系统回顾与荟萃分析。
IF 4.1 3区 医学
Contact Lens & Anterior Eye Pub Date : 2024-07-18 DOI: 10.1016/j.clae.2024.102169
{"title":"The efficacy of vitamin D supplementation in dry eye disease: A systematic review and meta-analysis","authors":"","doi":"10.1016/j.clae.2024.102169","DOIUrl":"10.1016/j.clae.2024.102169","url":null,"abstract":"<div><h3>Purpose</h3><p>Vitamin D (VD) is a vitamin with anti-inflammatory and immunomodulatory effects. Several studies have shown that VD deficiency is associated with the incidence and severity of dry eye disease (DED) in humans. This <em>meta</em>-analysis compared signs and symptoms in patients with DED before and after VD supplementation.</p></div><div><h3>Methods</h3><p>Ten databases (PubMed, Cochrane, Web of science, Ovid, Embase, Scopus, CNKI, CSTJ, Wanfang, Sinomed) and four clinical trials registry websites (ISRCTN, CT, ICTRP, ICH GCP) were searched for studies on the efficacy of VD supplement in patients with DED that were published up to 2023 January. A total of 8 studies with 439 cases were included. Two reviewers independently assessed the quality of the literature and extracted data to calculate standard mean differences (SMD) for the Schirmer's test (SH test), tear film break-up time (TBUT), corneal fluorescein staining scores (CFSS, Oxford Scale, 0–5), lid hyperemia, ocular surface disease index (OSDI), and visual analogue pain scale (VAS).</p></div><div><h3>Results</h3><p>The analysis showed that VD supplementation improved tear production (SMD 1.43, 95% CI 0.81, 2.05, p = 0.000) and tear film stability (SMD 1.19, 95% CI 0.83, 1.55, p = 0.000) and reduced lid hyperemia (SMD −0.71, 95% CI −1.09, −0.32, p = 0.000) and OSDI (SMD −1.10, 95% CI −1.45, −0.74, p = 0.000), which is effective in alleviating the signs and symptoms of DED.</p></div><div><h3>Conclusions</h3><p>VD supplementation could be an adjuvant treatment to alleviate the signs and symptoms of dry eye in the future. However, further studies regarding its most appropriate administration and dosage need to be conducted.</p></div>","PeriodicalId":49087,"journal":{"name":"Contact Lens & Anterior Eye","volume":null,"pages":null},"PeriodicalIF":4.1,"publicationDate":"2024-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1367048424000614/pdfft?md5=1d21bf2840d78c8c9c8ac7a6dacf745d&pid=1-s2.0-S1367048424000614-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141724831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing blink dynamics with non-noticeable method. 用不易察觉的方法评估眨眼动态。
IF 4.1 3区 医学
Contact Lens & Anterior Eye Pub Date : 2024-07-13 DOI: 10.1016/j.clae.2024.102277
Yakup Acet
{"title":"Assessing blink dynamics with non-noticeable method.","authors":"Yakup Acet","doi":"10.1016/j.clae.2024.102277","DOIUrl":"https://doi.org/10.1016/j.clae.2024.102277","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of the study was to demonstrate the feasibility of blink dynamics with a contactless, non-noticeable method without any visible light being reflected to the participant's eye by the device, and to investigate the blink dynamics parameters in 39 participants whose blink dynamics were examined with this method. It was also aimed to explain the potential of corneal topography devices for non-noticeable blink dynamics and elucidate some tips to device manufacturers to make them practical.</p><p><strong>Methods: </strong>A one-minute real-time video image in the meibography module of the scheimpflug camera-based corneal topography device was recorded in the slow motion mode of the mobile phone. Detailed analysis of blink dynamics was made by advancing the video images manually at 10 ms intervals. Lid Closing Time (LCT), Lid Opening Time (LOT), third Interblink Interval times (IBI<sub>(3)</sub>), fifth Interblink Interval times (IBI<sub>(5)</sub>), Number of Blinks Per Minute (NoB), Number of Complete Blinks Per Minute (NoCB), Number of Incomplete Blinks Per Minute (NoICB) were investigated.</p><p><strong>Results: </strong>The average NoB, NoCB, and NoICB (blinks/minute) with ± standard deviation (SD) values were found to be 22.9 ± 14.4; 14.5 ± 12.4 and 8.4 ± 8, respectively. The average IBI<sub>(3)</sub> time(seconds) with ± SD was measured as 3.4 ± 4.5. The average IBI<sub>(5)</sub> time (seconds) with ± SD was 3.9 ± 3.7 The average LCT time (milliseconds) with ± SD was found to be 91.9 ± 36.9 in the 4 different blinks analyzed. The average LOT time (milliseconds) with ± SD was found to be 582.6 ± 196.5 in the 3 different blinks analyzed.</p><p><strong>Conclusions: </strong>Blink dynamics can be examined in detail with corneal topography devices in a non-contact, no visible light, and most importantly, non-noticeable manner. Existing video imaging modules of corneal topography devices have the potential to investigate blink dynamics. It is anticipated that the clinical use of blink dynamics, which can be performed practically, will increase, particularly in the monitoring of ocular surface and neurological diseases.</p>","PeriodicalId":49087,"journal":{"name":"Contact Lens & Anterior Eye","volume":null,"pages":null},"PeriodicalIF":4.1,"publicationDate":"2024-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141617475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The safety of orthokeratology contact lens wear in slowing the axial elongation of the eye in children. 佩戴矫形角膜接触镜在减缓儿童眼轴伸长方面的安全性。
IF 4.1 3区 医学
Contact Lens & Anterior Eye Pub Date : 2024-07-12 DOI: 10.1016/j.clae.2024.102258
Jacinto Santodomingo-Rubido, Sin-Wan Cheung, César Villa-Collar
{"title":"The safety of orthokeratology contact lens wear in slowing the axial elongation of the eye in children.","authors":"Jacinto Santodomingo-Rubido, Sin-Wan Cheung, César Villa-Collar","doi":"10.1016/j.clae.2024.102258","DOIUrl":"https://doi.org/10.1016/j.clae.2024.102258","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the safety of orthokeratology contact lens wear in slowing the axial elongation of the eye in myopic children.</p><p><strong>Methods: </strong>Safety data from three prospective studies, which evaluated the use of orthokeratology for slowing myopia progression in children in comparison to a parallel control group of single-vision spectacle lens wearers over a 2-year period, were pooled together for analysis. The primary and secondary safety endpoints are the comparisons of adverse events and slit-lamp findings grades ≥ 2 between orthokeratology and control groups, respectively.</p><p><strong>Results: </strong>Collectively, data from 125 orthokeratology and 118 control subjects were analyzed in this study. Of these, 101 (81 %) and 88 (75 %) orthokeratology and control subjects completed the 2-year follow-up period, respectively. Nineteen orthokeratology subjects experienced 28 adverse events, of which 6 were significant, whereas just one adverse event was found in the control group; this difference was statistically significant (p < 0.001). Most adverse events found in the orthokeratology group were corneal in nature, primarily corneal abrasion/staining, accounting for around 40 % of all adverse events. Of the 28 adverse events, only 18 (3 significant) are likely to be contact lens-related, leading to incidence rates of total and device-related adverse events per 100 patient years of lens wear (95 % confidence intervals) of 13.1 (9.2-18.2) and 8.4 (5.4-10.7), respectively. No significant differences were found between groups in the total number of silt-lamps findings with grades ≥ 2 (p > 0.05).</p><p><strong>Conclusion: </strong>Around 13% of eyes wearing overnight orthokeratology contact lenses are likely to experience an adverse event over one year of lens wear, with this figure being lower when considering device-related adverse events alone. No serious adverse events were found, with most being non-significant. These results inform eye care practitioners on the safety of orthokeratology lenses when prescribed for slowing myopia progression to myopic children.</p>","PeriodicalId":49087,"journal":{"name":"Contact Lens & Anterior Eye","volume":null,"pages":null},"PeriodicalIF":4.1,"publicationDate":"2024-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141604364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
International trends in prescribing toric soft contact lenses to correct astigmatism (2000–2023): An update 为矫正散光而配戴散光软性隐形眼镜的国际趋势(2000-2023 年):更新。
IF 4.1 3区 医学
Contact Lens & Anterior Eye Pub Date : 2024-07-11 DOI: 10.1016/j.clae.2024.102276
{"title":"International trends in prescribing toric soft contact lenses to correct astigmatism (2000–2023): An update","authors":"","doi":"10.1016/j.clae.2024.102276","DOIUrl":"10.1016/j.clae.2024.102276","url":null,"abstract":"<div><h3>Purpose</h3><p>There have been significant advancements in toric soft contact lens design and manufacturing technology, and increased product availability, over the past half a century. The purpose of this work is to update earlier surveys by describing international trends in toric soft lens fitting between 2000 and 2023, inclusive.</p></div><div><h3>Method</h3><p>An annual contact lens prescribing survey was sent to eye care practitioners in up to 71 countries between 2000 and 2023, inclusive. Data relating to 220,934 standard soft daily wear single vision lens fits undertaken in 20 countries returning reliable longitudinal data were analysed in respect of toric soft lens fitting.</p></div><div><h3>Results</h3><p>Overall, toric soft lens prescribing almost doubled over the time-course of this survey, from 24.4 % of standard soft daily wear single vision lens fits in 2000 to 46.2 % in 2023 (p &lt; 0.0001). There were significant differences between countries in toric soft lens prescribing (p &lt; 0.0001). Of all standard soft daily wear single vision contact lenses prescribed to males, 32.0 % were toric soft lenses, compared with 28.7 % for females (p &lt; 0.0001). The mean age of toric soft lens wearers was 30.5 ± 12.5 years, compared to 27.9. ± 12.1 years for spherical soft lens wearers (p &lt; 0.0001). Analysis of 13,582 recent toric soft lens fits (2019–2023, inclusive), in terms of material type and replacement frequency, revealed the following proportions: reusable silicone hydrogel – 51 %; daily disposable silicone hydrogel – 27 %; daily disposable hydrogel – 12 %; and reusable hydrogel – 10 %.</p></div><div><h3>Conclusion</h3><p>There has been a substantial increase in toric soft lens fitting throughout the 24 years of this survey, to a point whereby almost all clinically significant astigmatism is being corrected among those wearing standard soft daily wear single vision lenses.</p></div>","PeriodicalId":49087,"journal":{"name":"Contact Lens & Anterior Eye","volume":null,"pages":null},"PeriodicalIF":4.1,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1367048424001681/pdfft?md5=7063e6af357a3c6eb13af2484bb7f52c&pid=1-s2.0-S1367048424001681-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141602027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Classification of dry eye disease subtypes 干眼症亚型分类。
IF 4.1 3区 医学
Contact Lens & Anterior Eye Pub Date : 2024-07-04 DOI: 10.1016/j.clae.2024.102257
{"title":"Classification of dry eye disease subtypes","authors":"","doi":"10.1016/j.clae.2024.102257","DOIUrl":"10.1016/j.clae.2024.102257","url":null,"abstract":"<div><h3>Purpose</h3><p>The current subclassifications of dry eye disease (DED) are aqueous deficient (ADDE) and evaporative (EDE) forms, but there lacks consistency in the clinical characteristics used to define each of these. This study used clinical data to inform cut-off values for the subclassification of ADDE and EDE, to allow more consistent study of the epidemiology of both DED subtypes.</p></div><div><h3>Methods</h3><p>The study enrolled 261 residents from the UK, extracted from a cohort with demographics representing the population (mean 42.4 ± 18.7 years, 56 % females). The TFOS DEWS II diagnostic criteria were used to identify those with DED. Meibomian gland loss/drop-out (from meibography), lipid layer thickness (LLT − from interferometry graded on the Guillon-Keeler scale), and tear meniscus height (TMH − Keratograph 5M) along with tear evaporation (Delfin Vapometer) were used to characterise the subclassification. The Dry Eye Risk Factor Survey was used to assess risk factors associated with each DED subtype.</p></div><div><h3>Results</h3><p>Compared to individuals who were not diagnosed with DED, EDE was characterized by signs of meibomian gland loss of &gt; 28 %, LLT grade &lt; 3 and tear evaporation &gt; 46 g/m<sup>2</sup>/h. In contrast, ADDE was best characterized by a reduced TMH &lt; 0.2 mm. Based on these criteria, the prevalence of ADDE was 6.2 %, EDE was 64.2 %, and 11.1 % exhibited features of both ADDE and EDE, with 18.5 % unclassified despite having a DED diagnosis. Contact lens wear and computer use were risk factors for ADDE (p &lt; 0.05), whereas age was a positive risk factor for EDE (p &lt; 0.01). Meibomian gland loss (occurring in 27.9 %) was the most commonly observed sign in EDE.</p></div><div><h3>Conclusions</h3><p>Data driven-classification of DED confirms that the evaporative form is most prevalent and identified that in a generalisable UK population, ADDE alone occurs only in approximately 1 in 16 cases of DED.</p></div>","PeriodicalId":49087,"journal":{"name":"Contact Lens & Anterior Eye","volume":null,"pages":null},"PeriodicalIF":4.1,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1367048424001498/pdfft?md5=d16dd8e4bda6e891112e6317e9f10d7b&pid=1-s2.0-S1367048424001498-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141538871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Soft peripheral contact lens for eye elongation control (SPACE): 1-year results of a double-blinded randomized controlled trial 用于控制眼球拉长的软性周边接触镜(SPACE):双盲随机对照试验的 1 年结果。
IF 4.1 3区 医学
Contact Lens & Anterior Eye Pub Date : 2024-07-03 DOI: 10.1016/j.clae.2024.102256
{"title":"Soft peripheral contact lens for eye elongation control (SPACE): 1-year results of a double-blinded randomized controlled trial","authors":"","doi":"10.1016/j.clae.2024.102256","DOIUrl":"10.1016/j.clae.2024.102256","url":null,"abstract":"<div><h3>Purpose</h3><p>To examine the safety and efficacy of soft multifocal contact lenses on slowing the rate of myopia progression.</p></div><div><h3>Methods</h3><p>A prospective, randomized, double-masked clinical trial was conducted including 115 children (55 boys and 60 girls) aged 8 to 15 years. Children were assigned to wear one of two daily disposable soft contact lens designs; a multifocal design (Pegavision) or a dual-focus design (MiSight, Coopervision) in both eyes for at least 8 h per day for one year. All contact lenses were replaced on a daily basis. Measurements were obtained using a logMAR vision meter, including objective refraction, handheld retinoscopy, high (96 %) and low (12 %) contrast sensitivity, and distance and near visual acuity. Axial length was measured every 6 months.</p></div><div><h3>Results</h3><p>After one year, the spherical equivalent refractive error and axial length of the experimental group (Pegavision) increased by −0.50 ± 0.48 D and 0.24 ± 0.16 mm, respectively, in the right eye and −0.47 ± 0.37 D and 0.23 ± 0.16 mm, respectively, in the left eye. The spherical equivalent refractive error and axial length of the control group (MiSight) increased by −0.48 ± 0.47 D and 0.22 ± 0.13 mm, respectively, in the right eye and by −0.50 ± 0.44 D and 0.23 ± 0.14 mm, respectively, in the left eye, with no significant differences observed between the two lens types.</p></div><div><h3>Conclusions</h3><p>The one-year results from this clinical trial show that the multifocal soft contact lenses used in the experimental group have a similar myopia control efficacy with respect to spherical equivalent refraction and axial length elongation as a commercially available dual focus soft contact lens design.</p></div>","PeriodicalId":49087,"journal":{"name":"Contact Lens & Anterior Eye","volume":null,"pages":null},"PeriodicalIF":4.1,"publicationDate":"2024-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1367048424001486/pdfft?md5=2aa6edb4a38b9f82720d5c4e0fe47f70&pid=1-s2.0-S1367048424001486-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141535686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
International trends in daily disposable contact lens prescribing (2000-2023): An update. 日抛型隐形眼镜处方的国际趋势(2000-2023 年):更新。
IF 4.1 3区 医学
Contact Lens & Anterior Eye Pub Date : 2024-06-30 DOI: 10.1016/j.clae.2024.102259
Philip B Morgan, Nathan Efron, Craig A Woods, Deborah Jones, Lyndon Jones, Jason J Nichols
{"title":"International trends in daily disposable contact lens prescribing (2000-2023): An update.","authors":"Philip B Morgan, Nathan Efron, Craig A Woods, Deborah Jones, Lyndon Jones, Jason J Nichols","doi":"10.1016/j.clae.2024.102259","DOIUrl":"https://doi.org/10.1016/j.clae.2024.102259","url":null,"abstract":"<p><strong>Purpose: </strong>Daily disposable contact lenses offer numerous benefits in terms of ocular health and wearer convenience. The purpose of this work is to update earlier surveys by describing global trends in daily disposable lens fitting between 2000 and 2023.</p><p><strong>Method: </strong>An annual contact lens prescribing survey was sent to eye care practitioners in up to 71 countries between 2000 and 2023, inclusive. Data relating to 265,106 daily wear soft lens fits undertaken in 20 countries returning reliable longitudinal data were analysed in respect of daily disposable lens fitting.</p><p><strong>Results: </strong>Overall, daily disposable lens prescribing increased over time, from 17.1 % of daily wear soft lens fits in 2000 to 46.7 % in 2023 (p < 0.0001). There were significant differences between countries in daily disposable lens prescribing (p < 0.0001), and between the percentage of males fitted with daily disposable lenses, as a proportion of all daily wear soft lenses (37.2 %), compared to females (35.2 %) (p < 0.0001). Daily disposable lens wearers are slightly younger at fitting than reusable soft lens wearers (31.0 vs 31.2 years, respectively) (p < 0.0001), although this difference is not clinically meaningful. Analysis of 50,240 daily wear soft lenses fitted recently (2019-2023) were found to be prescribed for the following replacement frequencies: daily - 47 %; monthly - 42 %; 1-2 weekly - 9 %; and ≥3 monthly - 2 %.</p><p><strong>Conclusion: </strong>There has been a substantial increase in daily disposable lens fitting throughout the first 24 years of this century. The gradual nature of this increase is commensurate with the staged introduction of daily disposable lens designs and expanded parameter ranges over the survey period.</p>","PeriodicalId":49087,"journal":{"name":"Contact Lens & Anterior Eye","volume":null,"pages":null},"PeriodicalIF":4.1,"publicationDate":"2024-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141477780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信